Rat Genome Database
大鼠基因组数据库
基本信息
- 批准号:8021847
- 负责人:
- 金额:$ 185.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelBiologicalBiological ProcessBiologyBreedingChemicalsCollaborationsCommunitiesComparative StudyComplexDataData SetDatabasesDevelopmentDiseaseDisease PathwayDisease modelDrug InteractionsEducational ActivitiesElementsEnvironmentEquilibriumGene MutationGenesGeneticGenetic ModelsGenetic VariationGenomeGenomicsGenotypeGoalsGrantHealthHumanHuman GenomeImageryIndividualKnowledgeLinkLiteratureMammalian GeneticsMapsMeasurementMedical RecordsMethodsMiningModelingMolecularMusNatureOntologyPathway interactionsPharmaceutical PreparationsPhenotypePhysiologicalPhysiological ProcessesPositioning AttributeProcessProtocols documentationQuantitative Trait LociRNA SplicingRat StrainsRattusRegulatory PathwayReportingReproductionResearchResearch PersonnelResourcesSignal PathwaySingle Nucleotide PolymorphismSiteSoftware ToolsSystemTranslational ResearchVariantcomputerized data processingdata formatdisease phenotypeeditorialembryonic stem cellgene interactiongenetic variantgenome databasehuman diseaseinnovationinterestmeetingsmouse genomenovel diagnosticsphenomepublic health relevancerat genometooltool development
项目摘要
DESCRIPTION (provided by applicant): The Rat Genome Database provides a core resource for rat researchers combining genetic, genomic, pathway, phenotype and strain information with a focus on disease. The goal of RGD is to provide investigators with a research platform that facilitates the elucidation of disease mechanisms by implementing standard data formats and ontologies. To meet this goal, we propose three specific aims: 1) To acquire, integrate and functionally annotate emerging genomic elements and variations along with core data to create a comprehensive genome resource. New gene models, sequence and map data and variations such as single nucleotide polymorphisms (SNPs), copy number variants (CNVs), and splice variants will be integrated through collaborations with NCBI and Ensembl and the use of innovative data pipelines. Curators will continue to focus on functional annotation of core data using multiple ontologies. New information including chemical-gene, drug-gene interactions and their impact on biology or disease will be added. Tools will be developed for mining, analysis and visualization of new data types. Educational activities for this aim will focus on new users and new tools for existing users. 2) To create a comprehensive phenome resource including phenotype measurements and strain medical records. We will develop a phenome database and provide individual strain "medical records" to provide easy access to the richness of this information. The phenome resource will include specific educational activities focused on phenotyping protocols, breeding and the use of our new tools and strain resources. 3) To link genotypes (Aim 1) to phenotypes (Aim 2) through QTLs, molecular, cellular and physiological pathways and the disease portals. RGD will continue to curate QTL data and enhance the QTL reports to provide a navigational hub linking genotype and phenotype data. Drug and physiological pathways will be curated in addition to disease related signaling and regulatory pathways and interactive diagrams will be used to link pathways, biological processes, genomic variations and phenotype data. RGD will expand its Disease Portals to serve as integration points for genomic and phenotype data, disease model profiles, and pathway data. Educational activities will focus on tools for comparative studies between rat and human, as well as those which integrate genotype and phenotype data.
PUBLIC HEALTH RELEVANCE: The rat has been a primary animal model used to study many complex diseases and physiological processes. The combination of available genomic resources with the biological relevance and wealth of phenotypic data that exists for the rat provides an opportunity to advance the understanding of disease processes and develop new diagnostic, preventative and treatment approaches. However, the large and often disparate data sets are difficult to gain knowledge from. The primary goal of RGD is to reduce the complex data sets, and large volume of literature into a discovery platform that provides support for researchers using the rat as a model organism in which to understand human health and disease through disease-oriented translational research.
描述(由申请人提供):大鼠基因组数据库为大鼠研究人员提供了一个核心资源,将遗传、基因组、途径、表型和菌株信息与重点放在疾病上。RGD的目标是为研究人员提供一个研究平台,通过实施标准的数据格式和本体来促进疾病机制的阐明。为了实现这一目标,我们提出了三个具体目标:1)获取、整合和在功能上注释新出现的基因组元件和变异以及核心数据,以创建一个全面的基因组资源。新的基因模型、序列和地图数据以及变异,如单核苷酸多态(SNPs)、拷贝数变异(CNV)和剪接变异,将通过与NCBI和EnSembl的合作以及创新数据管道的使用来整合。馆长将继续专注于使用多个本体对核心数据进行功能性注释。将增加新的信息,包括化学-基因、药物-基因相互作用及其对生物学或疾病的影响。将开发新数据类型的挖掘、分析和可视化工具。为此目的开展的教育活动将侧重于新用户和现有用户的新工具。2)建立包括表型测定和品系病历在内的综合表型资源。我们将开发一个表型数据库,并提供个体品系“病历”,以方便获取丰富的信息。表型组资源将包括特定的教育活动,重点是表型鉴定协议、育种以及我们新工具和菌株资源的使用。3)通过QTL、分子、细胞和生理途径以及疾病门户,将基因类型(目标1)与表型(目标2)联系起来。RGD将继续整理QTL数据并增强QTL报告,以提供一个连接基因和表型数据的导航枢纽。除了疾病相关的信号和调节途径外,还将对药物和生理途径进行管理,并将使用互动图将途径、生物过程、基因组变异和表型数据联系起来。RGD将扩大其疾病门户网站,作为基因组和表型数据、疾病模型概况和途径数据的集成点。教育活动将侧重于老鼠和人类之间的比较研究工具,以及那些整合了基因和表型数据的工具。
公共卫生相关性:大鼠一直是研究许多复杂疾病和生理过程的主要动物模型。现有的基因组资源与大鼠现有的生物学相关性和丰富的表型数据相结合,为促进对疾病过程的理解和开发新的诊断、预防和治疗方法提供了机会。然而,很难从庞大且往往完全不同的数据集中获取知识。RGD的主要目标是将复杂的数据集和大量文献减少到一个发现平台,为研究人员使用大鼠作为模式生物通过面向疾病的翻译研究了解人类健康和疾病提供支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOWARD J JACOB其他文献
HOWARD J JACOB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOWARD J JACOB', 18)}}的其他基金
Evaluation of human variants in disease models for end stage renal disease
终末期肾病疾病模型中人类变异的评估
- 批准号:
9116554 - 财政年份:2015
- 资助金额:
$ 185.02万 - 项目类别:
Evaluation of Human Variants in Disease Models for End Stage Renal Disease
终末期肾病疾病模型中人类变异的评估
- 批准号:
8968248 - 财政年份:2015
- 资助金额:
$ 185.02万 - 项目类别:
Clinical Genome Wide Sequencing Core for the Undiagnosed Disease Network
未确诊疾病网络的临床全基因组测序核心
- 批准号:
9140013 - 财政年份:2015
- 资助金额:
$ 185.02万 - 项目类别:
Clinical Genome Wide Sequencing Core for the Undiagnosed Disease Network
未确诊疾病网络的临床全基因组测序核心
- 批准号:
8774033 - 财政年份:2014
- 资助金额:
$ 185.02万 - 项目类别:
Gene targeted rat resource for the study of complex disease
用于复杂疾病研究的基因靶向大鼠资源
- 批准号:
8475961 - 财政年份:2013
- 资助金额:
$ 185.02万 - 项目类别:
Gene targeted rat resource for the study of complex disease
用于复杂疾病研究的基因靶向大鼠资源
- 批准号:
8729003 - 财政年份:2013
- 资助金额:
$ 185.02万 - 项目类别:
Genetic and Cellular Basis of Resistance/Sensitivity to Myocardial Ischemia
对心肌缺血的抵抗/敏感性的遗传和细胞基础
- 批准号:
7740008 - 财政年份:2009
- 资助金额:
$ 185.02万 - 项目类别:
Mechanistic characterization of genes for hypertension and renal disease.
高血压和肾脏疾病基因的机制特征。
- 批准号:
7853079 - 财政年份:2009
- 资助金额:
$ 185.02万 - 项目类别:
Mechanistic characterization of genes for hypertension and renal disease.
高血压和肾脏疾病基因的机制特征。
- 批准号:
7943022 - 财政年份:2009
- 资助金额:
$ 185.02万 - 项目类别:
Genetic and Cellular Basis of Resistance/Sensitivity to Myocardial Ischemia
对心肌缺血的抵抗/敏感性的遗传和细胞基础
- 批准号:
7900535 - 财政年份:2009
- 资助金额:
$ 185.02万 - 项目类别:
相似海外基金
Nitrous Oxide Management in a Novel Biological Process
新型生物过程中的一氧化二氮管理
- 批准号:
2789227 - 财政年份:2023
- 资助金额:
$ 185.02万 - 项目类别:
Studentship
Dynamic regulation of RNA modification and biological process
RNA修饰和生物过程的动态调控
- 批准号:
18H05272 - 财政年份:2018
- 资助金额:
$ 185.02万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2017
- 资助金额:
$ 185.02万 - 项目类别:
Discovery Grants Program - Individual
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2016
- 资助金额:
$ 185.02万 - 项目类别:
Discovery Grants Program - Individual
Organizing the Waterloo Biofilter biological process for treating wastewater concentrated by extreme water conservation plumbing
组织滑铁卢生物过滤器生物工艺处理通过极端节水管道浓缩的废水
- 批准号:
479764-2015 - 财政年份:2015
- 资助金额:
$ 185.02万 - 项目类别:
Engage Grants Program
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2015
- 资助金额:
$ 185.02万 - 项目类别:
Discovery Grants Program - Individual
Development of Biological Process for VOC treatment
VOC处理生物工艺的开发
- 批准号:
476672-2014 - 财政年份:2015
- 资助金额:
$ 185.02万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2014
- 资助金额:
$ 185.02万 - 项目类别:
Discovery Grants Program - Individual
Optimization of a biological process treating winery wastewater: anaerobic digestion integrated with Waterloo biofilter
处理酿酒厂废水的生物工艺优化:厌氧消化与滑铁卢生物过滤器集成
- 批准号:
463193-2014 - 财政年份:2014
- 资助金额:
$ 185.02万 - 项目类别:
Engage Grants Program
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2013
- 资助金额:
$ 185.02万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




